Green Eric Mark

Average Profitability
9.65%
Insider Buys Quantity
1
Insider Buys Sum
$2.01M
Insider Sells Quantity
7
Insider Sells Sum
$114.69M

Insider Activity of Green Eric Mark

According to the SEC Form 4 filings, Green Eric Mark, being in a position of

  1. President, CEO and Board Chair at West Pharmaceutical Services, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 160864 shares for $56.64M,
    over all time since 2015-05-21, has bought 36600 shares for $2.01M, and sold 336864 shares for $114.69M.

The largest purchase of all time was on 2015-05-21 and amounted to 36600 shares of West Pharmaceutical Services, Inc. for $2.01M.

The largest sale of all time was on 2024-05-07 and amounted to 66000 shares of West Pharmaceutical Services, Inc. for $24.2M.

Biography of Green Eric Mark

No biography is available at this moment.

2024-08-06SaleWest Pharmaceutical Services, Inc.
WST
President, CEO and Board Chair
30,732
0.0424%
$304.71$9.36M-0.91%
2024-05-07SaleWest Pharmaceutical Services, Inc.
WST
President, CEO and Board Chair
66,000
0.0906%
$366.65$24.2M-15.02%
2024-02-27SaleWest Pharmaceutical Services, Inc.
WST
President, CEO and Board Chair
64,132
0.0878%
$359.85$23.08M-8.56%
2023-08-08SaleWest Pharmaceutical Services, Inc.
WST
President & CEO
44,000
0.0585%
$394.77$17.37M-10.33%
2023-05-09SaleWest Pharmaceutical Services, Inc.
WST
President & CEO
44,000
0.0593%
$363.10$15.98M+1.92%
2023-03-07SaleWest Pharmaceutical Services, Inc.
WST
44,000
0.0592%
$322.35$14.18M+11.99%
2022-12-05SaleWest Pharmaceutical Services, Inc.
WST
President & CEO
44,000
0.059%
$238.99$10.52M+46.96%
2015-05-21PurchaseWest Pharmaceutical Services, Inc.
WST
Chief Executive Officer
36,600
0.051%
$54.89$2.01M+9.65%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.